BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 38504114)

  • 1. Multicenter integrated analysis of noncoding CRISPRi screens.
    Yao D; Tycko J; Oh JW; Bounds LR; Gosai SJ; Lataniotis L; Mackay-Smith A; Doughty BR; Gabdank I; Schmidt H; Guerrero-Altamirano T; Siklenka K; Guo K; White AD; Youngworth I; Andreeva K; Ren X; Barrera A; Luo Y; Yardımcı GG; Tewhey R; Kundaje A; Greenleaf WJ; Sabeti PC; Leslie C; Pritykin Y; Moore JE; Beer MA; Gersbach CA; Reddy TE; Shen Y; Engreitz JM; Bassik MC; Reilly SK
    Nat Methods; 2024 Apr; 21(4):723-734. PubMed ID: 38504114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-Throughput Approaches to Pinpoint Function within the Noncoding Genome.
    Montalbano A; Canver MC; Sanjana NE
    Mol Cell; 2017 Oct; 68(1):44-59. PubMed ID: 28985510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo CRISPR screening for novel noncoding RNA functional targets in glioblastoma models.
    Attenello FJ; Tsung K; Bishara I; Loh YE; Chen TC
    J Neurosci Res; 2021 Sep; 99(9):2029-2045. PubMed ID: 33969526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A genome-scale CRISPR interference guide library enables comprehensive phenotypic profiling in yeast.
    McGlincy NJ; Meacham ZA; Reynaud KK; Muller R; Baum R; Ingolia NT
    BMC Genomics; 2021 Mar; 22(1):205. PubMed ID: 33757429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted Transcriptional Repression in Bacteria Using CRISPR Interference (CRISPRi).
    Hawkins JS; Wong S; Peters JM; Almeida R; Qi LS
    Methods Mol Biol; 2015; 1311():349-62. PubMed ID: 25981485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-scale CRISPR pooled screens.
    Sanjana NE
    Anal Biochem; 2017 Sep; 532():95-99. PubMed ID: 27261176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPRi functional genomics in bacteria and its application to medical and industrial research.
    Enright AL; Heelan WJ; Ward RD; Peters JM
    Microbiol Mol Biol Rev; 2024 Jun; 88(2):e0017022. PubMed ID: 38809084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maximizing CRISPRi efficacy and accessibility with dual-sgRNA libraries and optimal effectors.
    Replogle JM; Bonnar JL; Pogson AN; Liem CR; Maier NK; Ding Y; Russell BJ; Wang X; Leng K; Guna A; Norman TM; Pak RA; Ramos DM; Ward ME; Gilbert LA; Kampmann M; Weissman JS; Jost M
    Elife; 2022 Dec; 11():. PubMed ID: 36576240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dual sgRNA library design to probe genetic modifiers using genome-wide CRISPRi screens.
    Guna A; Page KR; Replogle JM; Esantsi TK; Wang ML; Weissman JS; Voorhees RM
    BMC Genomics; 2023 Oct; 24(1):651. PubMed ID: 37904134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation and validation of versatile inducible CRISPRi embryonic stem cell and mouse model.
    Li R; Xia X; Wang X; Sun X; Dai Z; Huo D; Zheng H; Xiong H; He A; Wu X
    PLoS Biol; 2020 Nov; 18(11):e3000749. PubMed ID: 33253175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CASPR, an analysis pipeline for single and paired guide RNA CRISPR screens, reveals optimal target selection for long non-coding RNAs.
    Bergadà-Pijuan J; Pulido-Quetglas C; Vancura A; Johnson R
    Bioinformatics; 2020 Mar; 36(6):1673-1680. PubMed ID: 31681950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct characterization of cis-regulatory elements and functional dissection of complex genetic associations using HCR-FlowFISH.
    Reilly SK; Gosai SJ; Gutierrez A; Mackay-Smith A; Ulirsch JC; Kanai M; Mouri K; Berenzy D; Kales S; Butler GM; Gladden-Young A; Bhuiyan RM; Stitzel ML; Finucane HK; Sabeti PC; Tewhey R
    Nat Genet; 2021 Aug; 53(8):1166-1176. PubMed ID: 34326544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional Genomics via CRISPR-Cas.
    Ford K; McDonald D; Mali P
    J Mol Biol; 2019 Jan; 431(1):48-65. PubMed ID: 29959923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPhieRmix: a hierarchical mixture model for CRISPR pooled screens.
    Daley TP; Lin Z; Lin X; Liu Y; Wong WH; Qi LS
    Genome Biol; 2018 Oct; 19(1):159. PubMed ID: 30296940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR Interference (CRISPRi) and CRISPR Activation (CRISPRa) to Explore the Oncogenic lncRNA Network.
    Morelli E; Gulla' A; Amodio N; Taiana E; Neri A; Fulciniti M; Munshi NC
    Methods Mol Biol; 2021; 2348():189-204. PubMed ID: 34160808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SliceIt: A genome-wide resource and visualization tool to design CRISPR/Cas9 screens for editing protein-RNA interaction sites in the human genome.
    Vemuri S; Srivastava R; Mir Q; Hashemikhabir S; Dong XC; Janga SC
    Methods; 2020 Jun; 178():104-113. PubMed ID: 31494246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying essential long non-coding RNAs in cancer using CRISPRi-based dropout screens.
    Bril O; Schwarzmueller LJ; Moreno LF; Vermeulen L; Léveillé N
    STAR Protoc; 2023 Dec; 4(4):102588. PubMed ID: 37773752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional Knockdown in Pneumococci Using CRISPR Interference.
    Kjos M
    Methods Mol Biol; 2019; 1968():89-98. PubMed ID: 30929208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decoding the noncoding genome via large-scale CRISPR screens.
    Shukla A; Huangfu D
    Curr Opin Genet Dev; 2018 Oct; 52():70-76. PubMed ID: 29913329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells.
    Hendel A; Bak RO; Clark JT; Kennedy AB; Ryan DE; Roy S; Steinfeld I; Lunstad BD; Kaiser RJ; Wilkens AB; Bacchetta R; Tsalenko A; Dellinger D; Bruhn L; Porteus MH
    Nat Biotechnol; 2015 Sep; 33(9):985-989. PubMed ID: 26121415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.